Stock ALIM ALIMERA SCIENCES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Alimera Sciences, Inc.

Equities

ALIM

US0162592028

Delayed Nasdaq
Other stock markets
 11:07:38 2024-04-18 am EDT 		5-day change 1st Jan Change
3.475 USD -2.11% Intraday chart for Alimera Sciences, Inc. -9.74% -19.56%
Mar. 25 Maxim Initiates Alimera Sciences at Buy Rating With $10 Price Target MT
Mar. 19 Alimera Sciences, Inc. Announces First Patient Randomized in Radiation Retinopathy Trial Being Conducted by the DRCR Retina Network CI

Evolution of the average Target Price on Alimera Sciences, Inc.

Price target over the last 5 years

History of analyst recommendation changes

fd568811069b.y02qV7algFJ3k8XEFQaGAOyseJGIIOcu_sr3lwTQHhw.uBKTO4GV7jQ54r-hVDLfULvgTObiRYtEsv-R8jePbm6GfesBheDhEwbdlA~f082c2eabc57d11cf52ceb0ab1d878b3

Analyst Recommendations on Alimera Sciences, Inc.

Maxim Initiates Alimera Sciences at Buy Rating With $10 Price Target MT
Alliance Global Partners Upgrades Alimera Sciences to Buy From Neutral, Adjusts Price Target to $8 From $4.50 MT
HC Wainwright Adjusts Price Target on Alimera Sciences to $5 From $9, Keeps Buy Rating MT
Alliance Global Partners Downgrades Alimera Sciences to Neutral Rating From Buy, Adjusts Price Target to $4.50 From $11 MT
HC Wainwright Adjusts Price Target on Alimera Sciences to $9 From $8, Reiterates Buy Rating MT
HC Wainwright Adjusts Alimera Sciences' Price Target to $8 from $10, Keeps Buy Rating MT
HC Wainwright Adjusts Alimera Sciences Price Target to $10 From $12, Maintains Buy Rating MT
ALIMERA SCIENCES : Alliance Global Partners Adjusts Alimera Sciences PT to $14.50 From $16.50, Maintains Buy Rating MT
ALIMERA SCIENCES : HC Wainwright Adjusts Alimera Sciences PT to $12 From $16, Maintains Buy Rating MT
ALIMERA SCIENCES : HC Wainwright Adjusts Alimera Sciences' Price Target to $16 From $14, Maintains Buy Rating MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
3.55 USD
Average target price
8 USD
Spread / Average Target
+125.35%
High Price Target
10 USD
Spread / Highest target
+181.69%
Low Price Target
6 USD
Spread / Lowest Target
+69.01%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Alimera Sciences, Inc.

Maxim
Alliance Global Partners
HC Wainwright

Ratings for Alimera Sciences, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. ALIM Stock
  4. Consensus Alimera Sciences, Inc.